Objective: Until recently the generally accepted paradigm implied that urine of healthy people is sterile. In the present study, urine of healthy subjects was investigated by extended bacteriological methods. Material and Methods: Three midstream urine samples from 52 healthy subjects each (24 females, 28 males; 18-25 years of age) were investigated by an extended set of culture media for identification of facultative aerobic (FAB) and nonclostridial anaerobic bacteria (NCAB). Ward's method (Euclidean distance) was used for similarity analysis. Results: The bacterial count of FAB in urine was usually low (≤102 colony-forming units/ml) in both groups. In contrast, the bacterial count of NCAB was higher (≥103 colony-forming units/ml), at least in some species, with significant differences between genders. The average number of bacterial species found was 5.8 in female and 7.1 in male urine. Half of the females were assigned to a specific ‘female' microbial spectrum, different from that of males. In the mixed-gender clusters, the males showed a greater similarity among themselves. Conclusions: As also shown by other investigators, urine of healthy people is normally not sterile. The role of the routinely not cultivated bacteria in healthy and diseased subjects needs to be established. It may alter the diagnostics of infectious and inflammatory diseases of the urogenital tract.

Keywords:
Urinary tract infection, Healthy subjects, Microbiome, Facultative aerobic bacteria, Anaerobic bacteria
1.
Zasloff M: Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 2007;18:2810-2816.
2.
Kass EH: Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960;44:194-198.
3.
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-654.
4.
Wullt B, Sundén F: Asymptomatic bacteriuria with the model strain Escherichia coli 83972 protects against symptomatic urinary tract infections; in Naber KG, Schaeffer AJ, Heyns C, Matsumoto T, Shoskes D, Bjerklund-Johansen TE (eds): Urogenital Infections. Arnhem, European Association of Urology - International Consultation on Urological Diseases, 2010, pp 314-318. http://www.icud.info/urogenitalinfections.html (accessed August 2014).
5.
Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D'Elia C, Malossini G, Boddi V, Bartoletti R: The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 2012;55:771-777.
6.
Wagenlehner FME, Naber KG: Asymptomatic bacteriuria - shift of paradigm. Clin Infect Dis 2012;55:778-780.
7.
Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh M-J, Huang S-T, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL: Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 2012;10:174.
8.
Trautner BW, Bhimani RD, Amspoker AB, Hysong SJ, Garza A, Kelly PA, Payne VL, Nalk AD: Development and validation of an algorithm to recalibrate mental models and reduce diagnostic errors associated with catheter-associated bacteriuria. BMC Med Inform Decis Mak 2013;13:48-56.
9.
Meijer-Severs GJ, Aarnoudse JG, Mensink WF, Dankert J: The presence of antibody-coated anaerobic bacteria in asymptomatic bacteriuria during pregnancy. J Infect Dis 1979:140:653-658.
10.
Allen-Vercoe E: Antimicrobials. Genomics bringing the gut microbiota into focus through microbial culture: recent progress and future perspective. Curr Opin Microbiol 2013;16:625-629.
11.
Lecuit M, Eloit M: The human virome: new tools and concepts. Trends Microb 2013;21:510-515.
12.
Ward JH: Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963;58:236-244.
13.
Anderson M, Bollinger D, Hagler A, Hartwell H, Rivers B, Ward K, Steck TR: Viable but nonculturable bacteria are present in mouse and human urine specimens. J Clin Microbiol 2004;42:753-758.
14.
Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS: Assessing diversity of the female urine microbiota by high throughput sequencing of 16S RNA amplicons. BMC Microbiol 2011;11:244-251.
15.
Wolfe AJ, Toh E, Shibata N, Rang R, Kenton K, FritzGerald MP, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L: Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 2012;50:1376-1383.
16.
Hilt E, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger P: Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2014;52:871-876.
17.
Dong Q, Nelson DE, Toh E, Diao L, Gao X, Fortenberry JD, Van Der Pol B: The microbial communities in male first urine are highly similar to those in paired urethral swab specimens. PLoS One 2011;6:e19709.
18.
Nabokova IuL, Gudima IA, Kogan MI, Chernitskaia ML: Bacterial spectrum of the urine in young healthy women (in Russian). Urologiia 2010;5:7-10.
19.
Naboka IuL, Kogan MI, Vasil'eva LI, Gudima IA, Miroshnichenko EA, Ibishev KhS: Bacterial mixed infection in women with chronic recurrent cystitis (in Russian). Zh Mikrobiol Epidemiol Immunobiol 2011;1:8-12.
20.
Naboka IuL, Gudima IA, Ibishev KhS, Miroshnichenko EA, Kogan MI, Vasil'eva LI: Etiological structure and persistence factors in bacteria found in cases of chronic recurrent lower urinary tract infections in Russian). Urologiia 2011;6:12-15.
21.
Bondarenko VM, Matsulevich TV: Intestine Dysbacteriosis as Clinical and Laboratory Syndrome: Current State of the Problem. Moscow, GEOTAR-Media, 2007, pp 114-128.
22.
Menshikov VV: Methodology of Clinical Laboratory Studies. Moscow, Labora, 2009, pp 51-83.
23.
Maskell RM: The natural history of urinary tract infection women. Med Hypotheses 2010;74:802-806.
24.
Naber KG, Schito G, Botto H, Palou J, Mazzei T: Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008;54:1164-1178.
25.
Hooton TM, Roberts PL, Cox ME, Stapleton AE: Voided midstream urine culture and acute cystitis in premenopausal women. New Engl J Med 2013;369:1883-1891.
26.
Mohanty NK, Jolly BB: Incidence of anaerobic bacterial infection following transurethral instrumentation. Indian J Pathol Microbiol 1996;39:33-36.
27.
Imirzalioglu С, Hain Т, Chakraborty Т, Domann Е: Нidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia 2008;40:66-71.
28.
Nelson DE, Van der Pol B, Dong Q, Revanna KV, Fan B, Easwaran S, Sodergren E, Weinstock GM, Diao L, Fortenberry JD: Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One 2010;5:e14116.
29.
Naboka IuL, Gudima IA, Kogan MI, Ibishev KhS, Chernitskaia ML: The microbial spectrum of urine and bladder bioptic samples in women with chronic recurrent cystitis (in Russian). Urologiia 2013;4:16-18.
30.
Kogan MI, Pasechnik DG, Naboka IuL, Ibishev KhS, Gazaev ZI, Gudima IA: Non-clostridial anaerobic bacteria can cause acute pyelonephritis (an experimental trial) (in Russian). Urologiia 2012;2:8-13.
31.
Naboka IuL, Kogan MI, Gudima IA, Tchernitskaia ML, Ibishev KhS, Khasigov AV, Mitusova EV: Role of nonclostridial anaerobes in the development of infectious and inflammatory diseases of the urinary and reproductive systems (in Russian). Urologiia 2013;6:118-121.
32.
Xiao J, Ren L, Lv H, Ding Q, Lou S, Zhang W, Dong Z: Atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome: microbiological results from a case-control study. Urol Int 2013;91:410-416.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.